Delta-projection Imaging on Contrast-enhanced Ultrasound to Quantify Tumor Microvasculature and Perfusion

Academic Radiology

Volumn 16, Issue 1, 2009, Pages 71-78

  Sehgal, Chandra M ^a   Cary, Theodore W ^a   Arger, Peter H ^a   Wood, Andrew K W ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

angiogenesis; power Doppler; tumor perfusion; Ultrasound contrast agents; vascular disrupting agent

Indexed keywords

PERFLUTREN;

ALGORITHM; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DELTA PROJECTION; DOPPLER ECHOGRAPHY; FEMALE; GRAY SCALE ECHOGRAPHY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGE RECONSTRUCTION; LINEAR REGRESSION ANALYSIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME ECHOGRAPHY; TISSUE PERFUSION; TUMOR VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; IMAGE ENHANCEMENT; MELANOMA; MICE; MICE, INBRED C3H; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57049134081     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2008.07.013     Document Type: Article

References (23)

1. Hinnen P., and Eskens F.A. Vascular disrupting agents in clinical development. Br J Cancer 96 (2007) 1159-1165
2. Lippert J.W. Vascular disrupting agents. Bioorg Med Chem 15 (2007) 605-615
3. Wood A.K.W., Ansaloni S., Ziemer L.S., Lee W.M.F., Feldman M.D., and Sehgal C.M. The antivascular action of physiotherapy ultrasound on murine tumors. Ultrasound Med Biol 31 (2005) 1403-1410
4. Bunte R.M., Ansaloni S., Sehgal C.M., Lee W.M.F., and Wood A.K.W. Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm. Ultrasound Med Biol 32 (2006) 453-461
5. Tsai J.F., Makonnen S., Feldman M., Sehgal C.M., Maity A., and Lee W.M.F. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biol Ther 4 (2005) 1395-1400
6. Chen B., Pogue B.W., Luna J.M., Hardman R.L., Hoopes P.J., and Hasan T. Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clin Cancer Res 12 (2006) 917-923
7. Sehgal C.M., Arger P.H., Pugh C.R., Kirchofer J.I., Kotlar E.Y., and Bovee K.C. Comparison of power Doppler and B-scan sonography for renal imaging using a sonographic contrast agent. J Ultrasound Med 17 (1998) 751-756
8. Kamotani Y., Lee W.M., Arger P.H., Cary T.W., and Sehgal C.M. Multigated contrast-enhanced power Doppler to measure blood flow in mice tumors. Ultrasound Med Biol 29 (2003) 977-984
9. Lassau N., Koscielny S., Opolon P., et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol 36 (2001) 50-55
10. Iordanescu I., Becker C., Zetter B., Dunning P., and Taylor G.A. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. Radiology 222 (2002) 460-467
11. Goertz D.E., Yu J.L., Kerbel R.S., Burns P.N., and Foster F.S. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 62 (2002) 6371-6375
12. Niermann K.J., Fleischer A.C., Huamani J., et al. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. J Ultrasound Med 26 (2007) 749-756
13. Kim S.H., Lee J.M., Kim K.G., et al. Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions. Eur Radiol 16 (2006) 2444-2453
14. Clevert D., Jung E.M., Jungius K.P., Ertan K., and Kubale R. Value of tissue harmonic imaging (THI) and contrast harmonic imaging (CHI) in detection and characterisation of breast tumours. Eur Radiol 17 (2007) 1-10
15. Yamamoto K., Shiraki K., Nakanishi S., et al. 1.5 harmonic imaging sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma. World J Gastroenterol 11 (2005) 5607-5613
16. Forsberg F., Liu J.B., Shi W.T., et al. In vivo perfusion estimation using subharmonic contrast microbubble signals. J Ultrasound Med 25 (2006) 15-21
17. Wood A.K.W., Bunte R.M., Cohen J.D., Tsai J.H., Lee William M.-F., and Sehgal C.M. The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent. Ultrasound Med Biol 33 (2007) 1901-1910
18. Sehgal C.M., Arger P.H., Rowling S.E., Conant E.F., Reynolds C., and Patton J.A. Quantitative vascularity of breast masses by Doppler imaging: regional variations and diagnostic implications. J Ultrasound Med 19 (2000) 427-440
19. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
20. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
21. Wang Z., Tang J., An L., et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med 26 (2007) 757-762
22. Huber S., Helbich T., Kettenbach J., Dock W., Zuna I., and Delorme S. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US-early experience. Radiology 208 (1998) 485-489
23. Perini R, Choe R, Yodh AG, Sehgal C, Divgi CR, Rosen MA. Non-invasive assessment of tumor vasculature: techniques and clinical applications. Cancer Metastasis Rev. In press.